Company profile · Biotech & medical
Handa Pharmaceuticals
漢達生技醫藥股份有限公司 · 6620
What it does
Drafted and translated from cited sources, with links to the passages they are based on for your verification. Care is taken to translate its original meaning from Mandarin as closely as possible.
Handa Pharmaceuticals develops, designs, and markets 505(b)(2) new drugs and high-barrier generic drugs.[1]
The company specializes in the design of specialty pharmaceutical formulations with high technological barriers and patentability.[2]
Handa Pharmaceuticals is based in Taiwan.[2]
Monthly revenue
| Latest month | Revenue | Year on year | Month on month |
|---|---|---|---|
| 2026-10 | NT$66m | -24.8% | -6.5% |
2024-11 to 2026-10, monthly revenue.
Foreign investors
| Last 20 trading days | Net |
|---|---|
| 2026-10-12 to 2026-11-10 | +NT$465m |
Net buying (green) and selling (red) by foreign investors, NT$ at each day's close. All companies.
Facts
| Full English name | Handa Pharmaceuticals,Inc. |
|---|---|
| Chinese name | 漢達生技醫藥股份有限公司 |
| Stock code | 6620 (TPEx) |
| Industry | Biotech & medical |
| Founded | 08 May 2014 |
| Listed | 23 Dec 2025 |
| Paid-in capital | NT$1.7bn |
| Chairman | 劉芳宇 |
| President | 陳俊良 |
| Headquarters | 3F-1&3F-2, No23, Nanke 3rd Rd.,Xinshi Dist., Tainan City 74147,Taiwan |
| Website | http://www.handapharma.com.tw |
| Official business description | 研發、設計及銷售505(b)(2)新藥及高技術門檻學名藥 · 其他生技服務等業務 |
Facts from MOPS company basic information, retrieved 03 Nov 2026. The official business description is the company's own entry and can be out of date.
Sources
- MOPS 公司基本資料 漢達生技醫藥股份有限公司 · mops · retrieved 04 Nov 2026
- 首頁 - 漢達生技 · website · retrieved 04 Nov 2026
Using it at work? Join the team-plan waiting list